ConductScience.org, home

Paper31746940

Renal denervation: bleak past, brighter future.

Rayner B. Cardiovasc J Afr, 2019. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Renal denervation: bleak past, brighter future. Papers, record 31746940. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31746940

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Renal denervation: bleak past, brighter future.
PubMed
Journal
Cardiovasc J Afr
PubMed
Year
2019
PubMed
Publication types
Editorial, Comment
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2022-02-04
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rayner BBrian

Source PubMed

Download CSV of authors

Topics2

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
KidneyMajor topic
Denervation

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment on31746943Renal denervation: dark past, bright future?https://conductscience.org/library/papers/31746943

Source PubMed

Download CSV of comments and corrections

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126724178Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.Lancet2016https://conductscience.org/library/papers/26724178PubMed
229803590Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.Lancet2018https://conductscience.org/library/papers/29803590PubMed
324210779Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.Lancet2014https://conductscience.org/library/papers/24210779PubMed
431746943Renal denervation: dark past, bright future?Cardiovasc J Afr2019https://conductscience.org/library/papers/31746943PubMed
524678939A controlled trial of renal denervation for resistant hypertension.N Engl J Med2014https://conductscience.org/library/papers/24678939PubMed
629803589Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.Lancet2018https://conductscience.org/library/papers/29803589PubMed
724898552Catheter-based renal denervation for treatment of patients with treatment-resistant hypertension: 36 month results from the SYMPLICITY HTN-2 randomized clinical trial.Eur Heart J2014https://conductscience.org/library/papers/24898552PubMed
830015759European Society of Hypertension position paper on renal denervation 2018.J Hypertens2018https://conductscience.org/library/papers/30015759PubMed
925629715South African hypertension practice guideline 2014.Cardiovasc J Afr2014https://conductscience.org/library/papers/25629715PubMed
1029133354
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Hypertension2018https://conductscience.org/library/papers/29133354PubMed
1126693818Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study.Hypertension2016https://conductscience.org/library/papers/26693818PubMed
1219272490Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials.Am J Med2009https://conductscience.org/library/papers/19272490PubMed
1328859944Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.Lancet2017https://conductscience.org/library/papers/28859944PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31746940

GET https://conductscience.org/api/papers/v1/31746940/authors